Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 45

    Panacea Biotec hexavalent EasySix vaccine to cater to USD 1 billion market

    Panacea Biotec hexavalent EasySix vaccine to cater to USD 1 billion market

    Medical Dialogues Bureau31 Dec 2019 12:29 PM IST
    Panacea Biotec’s hexavalent vaccine, which can immunize patients against six diseases, including diphtheria, tetanus, hepatitis B and polio, will also...
    Universal Health Care Act presents opportunities for Indian pharma firms in Philippines: GlobalData

    Universal Health Care Act presents opportunities for Indian pharma firms in Philippines: GlobalData

    Medical Dialogues Bureau31 Dec 2019 9:45 AM IST
    India was found by the data analytics company to be the top import partner of the Philippines in 2018, contributing 12.6 per cent of the total...
    AstraZeneca-Merck Lynparza gets USFDA nod to treat pancreatic cancer

    AstraZeneca-Merck Lynparza gets USFDA nod to treat pancreatic cancer

    Medical Dialogues Bureau31 Dec 2019 9:30 AM IST
    Lynparza is already approved for ovarian and breast cancers, and its latest approval underscores the potential of PARP inhibitors for use in newer...
    Sol Gel Twyneo reduces acne marks in late-stage studies

    Sol Gel Twyneo reduces acne marks in late-stage studies

    Medical Dialogues Bureau31 Dec 2019 9:15 AM IST
    Sol Gel Technologies Ltd's Twyneo is a once-daily topical non-antibiotic cream containing a fixed-dose combination of encapsulated benzoyl peroxide...
    Rwanda to make own morphine to avoid US-style opioids crisis

    Rwanda to make own morphine to avoid US-style opioids crisis

    Medical Dialogues Bureau31 Dec 2019 9:00 AM IST
    New Delhi: It was something, the silence. Nothing but the scuff of her slip-on shoes as Madeleine Mukantagara walked through the fields to her first...
    CDSCO declares 37 drug samples including Ibuprofen, Vitamin B-Complex as Not of Standard Quality

    CDSCO declares 37 drug samples including Ibuprofen, Vitamin B-Complex as Not of Standard Quality

    Farhat Nasim30 Dec 2019 5:03 PM IST
    New Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 37 drugs including...
    Dr Reddys unveils generic version of Nitropress injection in US

    Dr Reddys unveils generic version of Nitropress injection in US

    Farhat Nasim30 Dec 2019 4:13 PM IST
    Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) is a generic version of Hospira Inc's Nitropress injection, 50 mg/2ml, it added, Dr Reddy's said...
    Indian pharma, healthcare sector poised for another year of robust growth

    Indian pharma, healthcare sector poised for another year of robust growth

    Medical Dialogues Bureau30 Dec 2019 9:30 AM IST
    "The Indian Pharmaceutical industry is a sunrise industry with a competitive advantage for India. We should leverage India's position by unleashing...
    Flexion Therapeutics gets USFDA nod to update product label for Zilretta to treat osteoarthritis knee pain

    Flexion Therapeutics gets USFDA nod to update product label for Zilretta to treat osteoarthritis knee pain

    Medical Dialogues Bureau30 Dec 2019 9:15 AM IST
    New Delhi: Flexion Therapeutics, Inc recently announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug...
    Antibiotics maker Melinta files for bankruptcy protection

    Antibiotics maker Melinta files for bankruptcy protection

    Medical Dialogues Bureau30 Dec 2019 9:00 AM IST
    Larger drugmakers, including AstraZeneca Plc, Novartis and Sanofi SA, have stopped developing antibiotics, while smaller players such as Achaogen Inc...
    Department of Pharmaceuticals to hire Technical Consultants on contract basis; Details

    Department of Pharmaceuticals to hire Technical Consultants on contract basis; Details

    Medical Dialogues Bureau29 Dec 2019 12:10 PM IST
    New Delhi: Through a recent release, the Department of Pharmaceuticals (DoP) has informed about the hiring of Technical Consultants in the department...
    Johnson and Johnson gets Chinese nod to import psoriasis drug Tremfya

    Johnson and Johnson gets Chinese nod to import psoriasis drug Tremfya

    Farhat Nasim29 Dec 2019 9:30 AM IST
    Johnson and Johnson (JnJ) is positioning Tremfya as a better alternative to Novartis’s Cosentyx as it seeks to take market share away from the...
    PrevNext

    Popular Stories

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Lupin Contributes Rs 21 crores in battle against COVID-19

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok